KIACTA - Biotech, Pharma and Life Science Channel

08:43 EDT 27th March 2017 | BioPortfolio

KIACTA™ (also known as eprodisate) is an orally bioavailable small molecule intended for the treatment of AA amyloidosis, an orphan indication that results from long-standing inflammatory conditions.

KIACTA™ is partenered with global private equity firm Auven Therapeutics (previously Celtic Therapeutics). Patients are currently being enrolled in a Phase III Confirmatory Study for KIACTA™. This pivotal study will be used to confirm the positive safety and efficacy results shown in the Phase II/III study previously conducted BELLUS Health.

PubMed Articles [0 Results]


News Articles [6 Associated News Articles listed on BioPortfolio]

BELLUS Health Inc BLU Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryBELLUS Health Inc BELLUS Health is a drug development company, which focuses on developing drugs for rare diseases. The company's lead product KIACTA, is an orally bioavailable small molecule i...

Ep. 34: Versant closes oversubscribed sixth healthcare-focused fund

Versant Ventures closes its newest fund, a new stem cell company is born in the MaRs Discovery District and Auven Therapeutics official pulls the plug on the KIACTA™ AA amyloidosis program. We have ...

BELLUS Health’s partner terminates KIACTA™ program for the treatment of AA amyloidosis

LAVAL, QC – As part of an update on projects in its pipeline, BELLUS Health reports its partner Auven Therapeutics, who acquired the rights to KIACTA™ from the company in 2010, has decided to ...

BRIEF-Bellus Health provides update on pipeline

* Auven Therapeutics has decided to terminate Kiacta program for treatment of AA Amyloidosis

After Failed Phase III, Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) to Terminate the KIACTA Program

  Life Sciences Jobs   ...

After Failed Phase III, Auven to Terminate the KIACTA Program

  Life Sciences Jobs   ...

Events [0 Results]


Companies [1 Associated Companies listed on BioPortfolio]

Auven Therapeutics

Auven Therapeutics is a private equity company focused on the healthcare industry. The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. ...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

A Phase IIa Proof-of-Concept Study of NC-503 in Patients With Type II Diabetes

The main objectives of the current study are to establish the safety and clinical proof-of-concept of NC-503 in inadequately controlled patients with Type 2 diabetes and features of metabo...


None available.

Medical and Biotech [MESH] Definitions

None available.

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

review and buy KIACTA market research data and corporate reports here

Channels Quicklinks